These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


593 related items for PubMed ID: 26433051

  • 1. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
    Hervé PL, Lorin V, Jouvion G, Da Costa B, Escriou N.
    Virology; 2015 Dec; 486():134-45. PubMed ID: 26433051
    [Abstract] [Full Text] [Related]

  • 2. A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.
    Hu H, Voss J, Zhang G, Buchy P, Zuo T, Wang L, Wang F, Zhou F, Wang G, Tsai C, Calder L, Gamblin SJ, Zhang L, Deubel V, Zhou B, Skehel JJ, Zhou P.
    J Virol; 2012 Mar; 86(6):2978-89. PubMed ID: 22238297
    [Abstract] [Full Text] [Related]

  • 3. A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
    Tan Y, Ng Q, Jia Q, Kwang J, He F.
    J Virol; 2015 Apr; 89(7):3712-22. PubMed ID: 25609802
    [Abstract] [Full Text] [Related]

  • 4. A unique and conserved neutralization epitope in H5N1 influenza viruses identified by an antibody against the A/Goose/Guangdong/1/96 hemagglutinin.
    Zhu X, Guo YH, Jiang T, Wang YD, Chan KH, Li XF, Yu W, McBride R, Paulson JC, Yuen KY, Qin CF, Che XY, Wilson IA.
    J Virol; 2013 Dec; 87(23):12619-35. PubMed ID: 24049169
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.
    Rockman S, Camuglia S, Vandenberg K, Ong C, Baker MA, Nation RL, Li J, Velkov T.
    Mol Immunol; 2013 Apr; 53(4):435-42. PubMed ID: 23127859
    [Abstract] [Full Text] [Related]

  • 7. The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.
    Velkov T, Ong C, Baker MA, Kim H, Li J, Nation RL, Huang JX, Cooper MA, Rockman S.
    Mol Immunol; 2013 Dec; 56(4):705-19. PubMed ID: 23933511
    [Abstract] [Full Text] [Related]

  • 8. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
    Yamashita A, Kawashita N, Kubota-Koketsu R, Inoue Y, Watanabe Y, Ibrahim MS, Ideno S, Yunoki M, Okuno Y, Takagi T, Yasunaga T, Ikuta K.
    Biochem Biophys Res Commun; 2010 Mar 19; 393(4):614-8. PubMed ID: 20152806
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antigenic epitopes in the hemagglutinin of Qinghai-type influenza H5N1 virus.
    Rudneva IA, Kushch AA, Masalova OV, Timofeeva TA, Klimova RR, Shilov AA, Ignatieva AV, Krylov PS, Kaverin NV.
    Viral Immunol; 2010 Apr 19; 23(2):181-7. PubMed ID: 20373998
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC, Lin CY, Tsou YT, Jan JT, Wu SC.
    J Virol; 2015 Jul 19; 89(14):7224-34. PubMed ID: 25948745
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.